Clinical Trial Update: Observational Prospective Study of Immune Checkpoint Inhibitors for Solid Neoplasms

View source ↗

Summary

An observational prospective study assessing immune checkpoint inhibitors for solid cancers; recruitment is ongoing under Fudan University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Fudan University | Conditions: Cancer | Status: RECRUITING